Rimonabant Redux and Strategies to Improve the Future Outlook of CB1 Receptor Neutral-Antagonist/Inverse-Agonist Therapies

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Obesity (Silver Spring, Md.) Md.), 2011-07, Vol.19 (7), p.1325-1334
Hauptverfasser:	Ward, Sara Jane, Raffa, Robert B.
Format:	Artikel
Sprache:	eng
Schlagworte:	Animals Appetite Depressants - adverse effects Appetite Depressants - therapeutic use Cannabinoid Receptor Modulators - antagonists & inhibitors Dexfenfluramine - adverse effects Dexfenfluramine - therapeutic use Drug Design Drug Inverse Agonism Humans Obesity - drug therapy Piperidines - adverse effects Piperidines - therapeutic use Pyrazoles - adverse effects Pyrazoles - therapeutic use Receptor, Cannabinoid, CB1 - antagonists & inhibitors Serotonin Receptor Agonists - adverse effects Serotonin Receptor Agonists - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!